Home
Storia in 6 fonti
Pfizer beats out Novo Nordisk in bidding for obesity drugmaker Metsera | Fortune
Metsera has no products on the market, but it is developing oral and injectable treatments.
- ·
forbes.com
Trump Says Obesity Drugmakers Will Cut GLP-1 Prices—Medicare Will Cover Some Costs
The deal also means Medicare will start covering obesity drugs for some patients for the first time beginning next year.
- ·
cnbc.com
Trump announces deals with Eli Lilly, Novo Nordisk to slash weight loss drug prices, offer some Medicare coverage
The deals are among the most politically significant announcements to date in the Trump administration's efforts to rein in high U.S. drug costs.
